Evaluation of a novel EphA2 targeting peptide for triple negative breast cancer based on radionuclide molecular imaging

A new strategy for the early diagnosis of triple-negative breast cancer (TNBC) is urgently needed however specific targets are lacking. EphA2 has been reported to be over-expressed in a variety of tumors, including TNBC, and is closely related to tumor progression. In this study, we designed a novel...

Full description

Bibliographic Details
Main Authors: Bin Qu, Yeming Han, Ting Liang, Chao Zhang, Guihua Hou, Feng Gao
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535222005275